BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

BIOL 2.65 -0.03 (-1.12%)
price chart
Biolase management overhauled amid bid to stanch a decade of red ink
Biolase Inc., a manufacturer and distributor of dental lasers, is pinning its turnaround hopes on a new management team. Biolase develops, manufactures and markets laser systems that are used in dental procedures.
Related articles »  
BIOLASE Inc (BIOL): Biolase: Management's Statements At Odds With The Facts
Management of Biolase (NASDAQ:BIOL) has repeatedly tried to mask bad news through the use of euphemistic and creative wording in disclosures and press releases.
Related articles »  
BIOLASE Launches New EPICb" X diode laser in the United States; Now ...
"Our EPIC X diode laser meets the highest quality and reliability standards we can set as a company, thereby maximizing chairside and hygiene room availability for dentists, hygienists and their patients," said BIOLASE, Inc. President and Chief ...
Oracle Partners Decisively Wins Shareholder Litigation Against Biolase, Inc.
GREENWICH, Conn., Jun 13, 2014 (BUSINESS WIRE) -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.
Related articles »  
BIOLASE Inc (BIOL): Biolase: What Will Happen Next ?
Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks. Two days ago I highlighted an ongoing plunge that had already begun at Biolase (NASDAQ:BIOL). Prior to my article, the shares had already ...
Related articles »  
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
GREENWICH, Conn., March 11, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board ...
BIOLASE Inc (BIOL) news: Biolase management faces proxy fight  Seeking Alpha
Related articles »  
BIOLASE SHAREHOLDER ALERT - Andrews & Springer LLC is Investigating ...
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating the Board of Directors of Biolase, Inc. ("Biolase" or the "Company") for possible corporate misconduct and violations ...
Related articles »  
Oracle Partners Responds to Disappointing Biolase, Inc. 2014 First Quarter ...
GREENWICH, Conn., May 14, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announced its disappointment with the financial and operating results of Biolase ...
Related articles »  
Update on Biolase - Oracle Partners fight for control (BIOL)
The Vice Chancellor of the Court of Chancery of the State of Delaware rules that shareholder Oracle Partners-backed Paul Clark's February 28, 2014 election to the board of directors is valid.
Related articles »  
Biolase (BIOL) Reports $35M Private Placement
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that investors including Jack W. Schuler, Oracle Partners, L.P.
BIOLASE to Raise $35 Million from Institutional and Individual Investors in ...  MarketWatch
Biolase to raise $35 million from institutional and individual investors in ...  Dentistry IQ
Related articles »